Acetaminophen 325 mg Tablets Regular Strength

Manufacturer
Akron Pharma Inc.
Effective date
2023-02-04
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 21:36:52

Label at a glance#

ProductACETAMINOPHEN
Active ingredientACETAMINOPHEN
Label structure9 sections

Indications and uses

To reduce fever and for the temporary relief of minor aches and pains due to: •headache •muscular aches •backache •minor pain of arthritis •the common cold •toothache •premenstrual and menstrual cramps. •Temporarily reduces fever.

Dosage and administration

 adults & children 12 years and over take 2 tablets every 4 to 6 hours while symptoms last do not take more than 10 tablets in 24 hours do not use for more than 10 days unless directed by a doctor  children 6-11 years  take 1 tablet every 4 to 6 hours while symptoms last do not take more than 5 tablets in 24 hours do not use for more than 5 days unless directed by a doctor  child under 6 years  ask a doctor

Storage and handling

store at temperature 15° to 30°C (59° to 86°F)

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Acetaminophen 325 mg

Purpose

OTC - PURPOSE SECTION

Pain Reliever/Fever Reducer

Uses

INDICATIONS & USAGE SECTION

To reduce fever and for the temporary relief of minor aches and pains due to:

•headache

•muscular aches

•backache

•minor pain of arthritis

•the common cold

•toothache

•premenstrual and menstrual cramps.

•Temporarily reduces fever.

Warnings

WARNINGS SECTION

Liver warning:

This product contains acetaminophen. Severe liver damage may occur if 

  • adult takes more than 4,000 mg of acetaminophen in 24 hours
  • child takes more than 5 doses in 24 hours 
  • taken with other drugs containing acetaminophen 
  • adult has 3 or more alcoholic drinks every day while using this product

Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include:

  • skin reddening 
  • blisters 
  • rash

If a skin reaction occurs, stop use and seek medical help right away.

Do not use

OTC - DO NOT USE SECTION

  • with any other drug containing acetaminophen (prescription or non-prescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
  • if the user has ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if the user has

OTC - ASK DOCTOR SECTION

  • has liver disease
  • is a child with pain of arthritis

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if your child is taking the blood thinning drug warfarin

Stop use and ask a doctor if:

OTC - STOP USE SECTION

  • pain gets worse or lasts more than 10 days (for adults) or 5 days (for children)
  • fever gets worse or lasts more than 3 days
  • new symptoms occur
  • redness or swelling is present.

These could be signs of a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Overdose Warning:

Taking more than the recommended dose (overdose) may cause liver damage. In case of overdose, get medical help or contact a Poison Control Center right away.(1-800-222-1222)

Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Directions - do not take more than directed (see overdose warning)

DOSAGE & ADMINISTRATION SECTION

 adults & children
12 years and over
  • take 2 tablets every 4 to 6 hours while symptoms last
  • do not take more than 10 tablets in 24 hours
  • do not use for more than 10 days unless directed by a doctor
 children 6-11 years
  •  take 1 tablet every 4 to 6 hours while symptoms last
  • do not take more than 5 tablets in 24 hours
  • do not use for more than 5 days unless directed by a doctor
 child under 6 years ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • store at temperature 15° to 30°C (59° to 86°F)

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, microcrystalline cellulose, polacrilin potassium, propylparaben, povidone, stearic acid.

Questions or Comments?

OTC - QUESTIONS SECTION

Call toll-free 1-877-225-6999

Manufactured for
Akron Pharma, Inc.,

373 RT US46 W Building E,

Suite 117, Fairfeld, NJ - 07004

Mfg. Lic. No: TN/DRUGS/558/1997

* This product is not manufactured or distributed by Johnson and Johnson, consumer inc., distributor of regular Tylenol Tablets.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

325mg - Unit Dose

325 UD325 UD

 325 mg -100 Tablets

325 mg-100325 mg-100

325mg -1000 Tablets

325 mg-1000325 mg-1000

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71399-8014-1EA - Each71399-80149f543106-0204-4f2d-8d0f-7097fb9d583012023-03-13
71399-8024-1EA - Each71399-802482550a85-78ed-49dc-acde-4e1fc1f0304f12021-03-02
71399-8024-2EA - Each71399-80245756bf41-abf2-4e25-aa92-5f3ef3cad1e312021-03-02

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71399-801471399-8014-1
71399-802471399-8024-1, 71399-8024-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8a6d9886-05a0-4727-96e8-69bbbf2dbc6b1475009d-9db7-4eea-93c3-1b1d548401cd2024-11-26WarningsExact identifier
spl set id: 1475009d-9db7-4eea-93c3-1b1d548401cd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.